Moreover, the suppression of PCSK9 using Alirocumab significantly decelerated the advancement of cardiovascular disease in aging rats, suggesting that PCSK9 is pivotal in cardiovascular aging [52]. This evidence concerns the gene PCSK9 and cardiovascular disorder.